4
Changes in Ownership
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001992324-26-000010
EVP, CFO & CBO sold 124,042 shares at an average $90.52 ($11,228,720)
- EVP, CFO & CBO acquired 124,042 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Savitz Ryan · EVP, CFO & CBO
Table I: Non-derivative
19 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-09 | Exercise or conversion : show line 1 in the form 10b5-1 | +29,276 | $17.88 | $523,455 | 29,276 | D |
| 2026-11-09 | Exercise or conversion : show line 2 in the form 10b5-1 | +20,608 | $21.77 | $448,636 | 49,884 | D |
| 2026-11-09 | Exercise or conversion : show line 3 in the form 10b5-1 | +40,430 | $22.07 | $892,290 | 90,314 | D |
| 2026-11-09 | Exercise or conversion : show line 4 in the form 10b5-1 | +10,399 | $8.44 | $87,768 | 100,713 | D |
| 2026-11-09 | Sale : show line 5 in the form 10b5-1 | −300 | $85.16 | $25,548 | 100,413 | D |
| 2026-11-09 | Sale : show line 6 in the form 10b5-1 | −700 | $86.70 | $60,690 | 99,713 | D |
| 2026-11-09 | Sale : show line 7 in the form 10b5-1 | −1,736 | $88.84 | $154,226 | 97,977 | D |
| 2026-11-09 | Sale : show line 8 in the form 10b5-1 | −37,517 | $90.12 | $3,381,032 | 60,460 | D |
| Open-market sales · 124,042 sh · avg $90.52 · $11,228,720 | ||||||
Table II: Derivative
10 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-11-09 | Exercise or conversion : show line 20 in the form 10b5-1 Stock Option (Right to Buy) | −29,276 | 42,500 | D |
| 2026-11-09 | Exercise or conversion : show line 21 in the form 10b5-1 Stock Option (Right to Buy) | −20,608 | 48,143 | D |
| 2026-11-09 | Exercise or conversion : show line 22 in the form 10b5-1 Stock Option (Right to Buy) | −40,430 | 109,570 | D |
| 2026-11-09 | Exercise or conversion : show line 23 in the form 10b5-1 Stock Option (Right to Buy) | −10,399 | 0 | D |
| 2026-11-10 | Exercise or conversion : show line 24 in the form 10b5-1 Stock Option (Right to Buy) | −1,301 | 46,842 | D |
| 2026-11-10 | Exercise or conversion : show line 25 in the form 10b5-1 Stock Option (Right to Buy) | −1,260 | 108,310 | D |
| 2026-11-11 | Exercise or conversion : show line 26 in the form 10b5-1 Stock Option (Right to Buy) | −1,744 | 45,098 | D |
| 2026-11-11 | Exercise or conversion : show line 27 in the form 10b5-1 Stock Option (Right to Buy) | −1,300 | 107,010 | D |
| 2026-11-12 | Exercise or conversion : show line 28 in the form 10b5-1 Stock Option (Right to Buy) | −1,339 | 43,759 | D |
| 2026-11-12 | Exercise or conversion : show line 29 in the form 10b5-1 Stock Option (Right to Buy) | −16,385 | 90,625 | D |
Loading xslF345X06/ownership.xml…